{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:03:05Z","timestamp":1648886585644},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.179","type":"journal-article","created":{"date-parts":[[2014,12,14]],"date-time":"2014-12-14T23:18:21Z","timestamp":1418599101000},"page":"179-185","source":"Crossref","is-referenced-by-count":0,"title":["Primary Central Nervous System Lymphoma in Miyazaki, Southwestern Japan, a Human T-Lymphotropic Virus Type-1 (HTLV-1)-Endemic Area: Clinicopathological Review of 31 Cases"],"prefix":"10.3960","volume":"54","author":[{"given":"Kazunari","family":"Maekawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Moriguchi-Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Kamiunten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Kubuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Asada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kousuke","family":"Marutsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Jaffe ES, Harris NL, Vardiman JM, Campo E, Arber DA: Hematopathology. St. Louis, Elsevier, pp.991-999, 2011"},{"key":"2","unstructured":"2 Shenkier TN, Blay JY, O&apos;Neill BP, Poortmans P, Thiel E, <i>et al<\/i>.: Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol 23:2233-2239, 2005"},{"key":"3","unstructured":"3 Kluin PM, Deckert M: Primary DLBCL of the CNS. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al<\/i>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.240-241, 2008"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, <i>et al<\/i>.: Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time ? Brain Tumor Pathol 28:145-149, 2011","DOI":"10.1007\/s10014-011-0020-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, <i>et al<\/i>.: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275-282, 2004","DOI":"10.1182\/blood-2003-05-1545"},{"key":"6","unstructured":"6 Louis DN, Ohgaki H, Wiester OD, Caveree WK <i>et al<\/i>.: WHO Classification of Tumours, Tumours of the Central Nervous System. 4th ed, Lyon, IARC, pp.188-192, 2007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Jahnke K, Korfel A, O&apos;Neill BP, Blay JY, Abrey LE, <i>et al<\/i>.: International study on low-grade primary central nervous system lymphoma. Ann Neurol 59:755-762, 2006","DOI":"10.1002\/ana.20804"},{"key":"8","unstructured":"8 Bataille B, Delwail V, Menet E, Vandermarcq P, Ingrand P, <i>et al.:<\/i> Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 92:261-266, 2000"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Hayabuchi N, Shibamoto Y, Onizuka Y: Primary central nervous system lymphoma in Japan: a nationwide survey. Int J Radiat Oncol Biol Phys 44:265-272, 1999","DOI":"10.1016\/S0360-3016(98)00564-1"},{"key":"10","unstructured":"10 Hayakawa T, Takakura K, Abe H, Yoshimoto T, Tanaka R, <i>et al.:<\/i> Primary central nervous system lymphoma in Japan: a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 19:197-215, 1994"},{"key":"11","unstructured":"11 Choi JS, Nam DH, Ko YH, Seo JW, Choi YL, <i>et al<\/i>.: Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas. Am J Surg Pathol 27:919-928, 2003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tseng MY, Tu YK, Shun CT: Primary central nervous system lymphoma: a retrospective study. J Clin Neurosci 5:409-412, 1998","DOI":"10.1016\/S0967-5868(98)90273-9"},{"key":"13","unstructured":"13 Stuver SO, Tachibana N, Okayama A, Romano F, Yokota T, <i>et al.:<\/i> Determinants of HTLV-1 seroprevalence in Miyazaki Prefecture, Japan: a cross-sectional study. J Acquir Immune Defic Syndr 5:12-18, 1992"},{"key":"14","unstructured":"14 Shibamoto Y, Ogino H, Suzuki G, Takemoto M, Araki N, <i>et al.:<\/i> Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004. Neuro Oncol 10:560-568, 2008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Dulai MS, Park CY, Howell WD, Smyth LT, Desai M, <i>et al.:<\/i> CNS T-cell lymphoma: an under-recognized entity? Acta Neuropathol 115:345-356, 2008","DOI":"10.1007\/s00401-007-0338-y"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Marshall AG, Pawson R, Thom M, Schulz TF, Scaravilli F, <i>et al.:<\/i> HTLV-I associated primary CNS T-cell lymphoma. J Neurol Sci 158:226-231, 1998","DOI":"10.1016\/S0022-510X(98)00111-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Suzumiya J, Marutsuka K, Nabeshima K, Nawa Y, Koono M, <i>et al<\/i>.: Autopsy findings in 47 cases of adult T-cell leukemia\/lymphoma in Miyazaki prefecture, Japan. Leuk Lymphoma 11:281-286, 1993","DOI":"10.3109\/10428199309087005"},{"key":"18","unstructured":"18 Camilleri-Bro\u00ebt S, Crini\u00e8re E, Bro\u00ebt P, Delwail V, Mokhtari K, <i>et al.:<\/i> A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107:190-196, 2006"},{"key":"19","unstructured":"19 Yamaguchi M, Seto M, Okamoto M, Ichinohasama R, Nakamura N, <i>et al<\/i>.: <i>De novo<\/i> CD5<sup>+<\/sup> diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99:815-821, 2002"},{"key":"20","unstructured":"20 Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, <i>et al.: De novo<\/i> CD5<sup>+<\/sup> diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Hematologica 93:1195-1202, 2008"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Imai H, Shimada K, Shimada S, Abe M, Okamoto M, <i>et al.:<\/i> Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma. Pathol Int 59:431-437, 2009","DOI":"10.1111\/j.1440-1827.2009.02390.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Ennishi D, Takeuchi K, Tokoyama M, Asahi H, Mishima Y, <i>et al.:<\/i> CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy. Ann Oncol 19:1921-1926, 2008","DOI":"10.1093\/annonc\/mdn392"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Amano M, Marutsuka K, Sugimoto T, Todaka T, Setoyama M: Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with adult T-cell leukemia\/lymphoma. J Dermatol 38:575-580, 2011","DOI":"10.1111\/j.1346-8138.2010.01120.x"},{"key":"24","unstructured":"24 Oyama T, Ichimura K, Suzuki R, Suzumiya J, Ohshima K, <i>et al.:<\/i> Senile EBV+ B-cell lymphoproliferative disorders:a clinicopathologic study of 22 patients. Am J Surg Pathol 27:16-26, 2003"},{"key":"25","unstructured":"25 Oyama T, Yamamoto K, Asano N, Oshiro A, Suzuki R, <i>et al.:<\/i> Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 13:5124-5132, 2007"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:47Z","timestamp":1621540007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/3\/54_179\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.179","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}